ASP Isotopes (NASDAQ:ASPI) Sets New 12-Month High - What's Next?

Key Points

• ASP Isotopes Inc. (NASDAQ:ASPI) reached a new 52-week high of $12.45 during trading, closing at $12.03 with a trading volume of 3,284,026 shares.
• Analysts have mixed ratings on ASP Isotopes, with Canaccord Genuity assigning a buy rating and a price target of $11.00, while Weiss Ratings gave a sell (d-) rating.
• In the second quarter, major institutional investors, including Rovida Advisors Inc. and Invesco Ltd., made significant stake increases in ASP Isotopes, indicating growing interest from large investors.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report)'s stock price reached a new 52-week high during mid-day trading on Monday . The company traded as high as $12.45 and last traded at $12.03, with a volume of 3284026 shares trading hands. The stock had previously closed at $10.13.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Weiss Ratings restated a "sell (d-)" rating on shares of ASP Isotopes in a research report on Wednesday, October 8th. Canaccord Genuity Group reiterated a "buy" rating and issued a $11.00 price objective on shares of ASP Isotopes in a report on Wednesday, September 17th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $11.00.

ASP Isotopes Price Performance

The business has a 50-day simple moving average of $9.51 and a 200 day simple moving average of $7.94. The firm has a market cap of $1.15 billion, a P/E ratio of -20.51 and a beta of 3.29. The company has a debt-to-equity ratio of 3.53, a quick ratio of 14.56 and a current ratio of 14.72.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last issued its earnings results on Thursday, August 14th. The company reported ($1.03) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.92). The business had revenue of $1.20 million for the quarter, compared to analysts' expectations of $1.60 million. ASP Isotopes had a negative net margin of 2,181.62% and a negative return on equity of 239.22%. On average, analysts anticipate that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year.

Insider Activity at ASP Isotopes

In other ASP Isotopes news, CEO Paul Elliot Mann sold 81,077 shares of the business's stock in a transaction that occurred on Tuesday, September 9th. The stock was sold at an average price of $8.39, for a total transaction of $680,236.03. Following the sale, the chief executive officer directly owned 8,084,191 shares of the company's stock, valued at $67,826,362.49. The trade was a 0.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Robert Ainscow sold 8,438 shares of the business's stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $8.53, for a total value of $71,976.14. Following the transaction, the chief operating officer owned 1,411,554 shares of the company's stock, valued at $12,040,555.62. This trade represents a 0.59% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 383,699 shares of company stock valued at $3,412,977 over the last ninety days. 21.40% of the stock is currently owned by company insiders.

Institutional Trading of ASP Isotopes

Large investors have recently modified their holdings of the company. Rovida Advisors Inc. purchased a new stake in ASP Isotopes in the second quarter valued at $16,148,000. Rovida Investment Management Ltd boosted its stake in shares of ASP Isotopes by 528.6% during the 2nd quarter. Rovida Investment Management Ltd now owns 2,200,000 shares of the company's stock worth $16,148,000 after acquiring an additional 1,850,000 shares in the last quarter. Exchange Traded Concepts LLC purchased a new stake in shares of ASP Isotopes during the 2nd quarter worth about $9,593,000. Sara Bay Financial purchased a new stake in shares of ASP Isotopes during the 3rd quarter worth about $8,688,000. Finally, Invesco Ltd. boosted its stake in shares of ASP Isotopes by 2,205.0% during the 2nd quarter. Invesco Ltd. now owns 471,219 shares of the company's stock worth $3,468,000 after acquiring an additional 450,776 shares in the last quarter. Hedge funds and other institutional investors own 16.80% of the company's stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.